Analystreport

Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Zynerba Pharmaceuticals, Inc.  (ZYNE) 
Last zynerba pharmaceuticals, inc. earnings: 3/10 06:50 am Check Earnings Report
US:NASDAQ Investor Relations: ir.zynerba.com